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Enactments of Race in the UK’s Blood
Stem Cell Inventory
ROSALIND WILLIAMS
Department of Sociological Studies, University of Sheffield, Sheffield, UK
Recent sociological analyses of the intersections of race and science recognise race’s
quality as an enacted object. Through this analytic lens, race is always materialising in
the practices and processes that enrol it and therefore enjoys a kind of multiplicity. The
context of blood stem cell transplantation, a scientific domain marked by a more and
less explicitly racialised logic, offers an opportunity to see the conceptual assertion of
race’s multiplicity play out. Indeed, an exploration of the UK’s stem cell inventory
reveals—through analysis of interviews, policy and parliamentary meetings—how race
materialises in the various practices that comprise this increasingly popular cancer
treatment option. Looking at practices of recruitment, inventory management and tissue
selection in particular provides an interesting window to look upon race and the many
signifiers that implicate it. These cases reveal moments of race’s stablisation and
silencing; its oscillation between the status of vital information to the life of a public
stem cell inventory, and of secondary data that provides little useful information to
clinicians selecting tissue. Adopting an analytic lens that attends to race’s multiple
enactments allows us to begin asking why enactments take the shape they do, and why
the particular practices that mobilise them come to be.
KEYWORDS: bone marrow, umbilical cord blood, race, ethnicity, donation
Introduction
‘It’s incredible to think there could be someone on the register who is essentially
your genetic twin.’ So said a UK stem cell donation charity spokesperson being
interviewed in February 2016 (BBC News, 2016). They were talking about the
small likelihood of being able to find a suitable stem cell donor for a stem cell
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transplant patient. The donor would need an almost identical human leukocyte
antigen (HLA) type to the recipient. The ability to speak of transplant at all is
in no small part to the work of mid-twentieth-century immunologists like Jean
Dausset, who discovered the first HLA in 1958. This triggered an effort to
locate all the HLAs in the human body (Dausset, 1958). The donor’s HLA type
is used to determine the suitability of a given unit of blood stem cells for the
growing number of medical treatments that require transplantation of donor
blood stem cells into the patient’s damaged immune system. The more alike the
donor and recipient HLA, the better.
Normally, clinicians look to a patient’s siblings who may share an identical
HLA type, and who might provide the stem cells required for transplantation.
In cases where a sibling match is not possible, clinicians can turn to stockpiles
of the ‘corporeal resource’ of stem cells (Brown et al., 2011). The two major
stockpiles are bone marrow registries and umbilical cord blood (UCB) banks.
The first, known as bone marrow or adult donor registries (herein, AD registries)
have been in operation since the 1970s (see Pavlů et al., 2011). These registries
retain HLA data of adult volunteers who may be called upon to provide cells at
some point.
UCB banks are the second key resource for clinicians. After the first clinical
intervention using UCB stem cells took place in 1988 (Gluckman et al., 1989),
clinical scientists began collecting and storing UCB stem cells into ‘banks’.
After the first was established in New York in 1993 (Rubinstein et al., 1995),
the UK’s National Blood Service built its own UCB bank in 1995 (National
Blood Service, 1997). Now, the World Marrow Donor Association (Petersdoorf,
2010) acts as an international standard-setting locus for banks and registries
around the world, which clinicians can then search when looking for stem cells
with HLA types compatible with their patients. In this paper I am interested in
those moments in which a sibling match is not possible and an unrelated donor
with an HLA type as similar to the patient as possible must be found.
Sociological attention to blood stem cells has looked at the various moral and
economic tensions at play in the contemporary landscape of blood stem cell
banking (Waldby, 2006; Dickenson, 2007; Martin et al., 2008; Waldby and
Cooper, 2010), but these interventions have not focused on a crucial feature
that figures centrally in this context: namely, ‘race’. In this paper, I want to ask,
after Amade M’charek (2013), how race is variously enacted in the context of
stem cell transplantation. How does it figure in the constitution of the stockpiling
of stem cells—the very structure of AD registries and UCB banks? What shape
does it take in reference to locating matches between donors and patients?
What is the form of race when donors are asked to identify themselves? The
asking of these questions relies on a conceptualisation of race as something
beyond fact and fiction, but as an object that gains and loses visibility and traction
through the practices of those who mobilise it.
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To answer these questions, then, I explore a number of practices from the blood
stem cell banking context: the recruitment of donors and the tools used to capture
their ‘ethnicity’ data; the manner in which blood stem cell collection is strategised
around comparing donor ethnicity information with census data; and some of the
complexities of selecting tissue from AD registries and UCB banks for transplan-
tation and how race figures in this practice. Looking at these different practices
reveals race not as a singular thing but as a multiple object, taking on different
shapes with the various practices that enact it. Through this, I seek to demonstrate
how—even in the singular context of blood stem cell banking—the various prac-
tices that constitute it enact race in various ways. Thus, race is never just one thing,
but has a quality of multiplicity to it, within, as well as between the particular con-
texts in which it emerges.
Analytic Perspectives: Theorising the Multiplicity of Race
A recent turn within the sociological study of race has been towards a more pro-
nounced focus on the practices in which race appears in more and less recognisa-
ble forms. Significant work has been undertaken in trying to explain why it is that
race sometimes feels like it is present in a context without being explicitly referred
to (Wade, 2014; Schwartz-Marı́n and Wade, 2015). This literature suggests that
the language of race is not simply being semantically sidestepped because of its
historical and political baggage. Rather, the world of referents that hint towards
race—for example, ‘population’, ‘ethnic group’, ‘ancestry’ and so on—speak to
race’s multiplicity (M’charek, 2013).
That is to say, explicit and implicit acknowledgements of ostensibly racial
logics of human difference take lots of shapes. This entails methodological and
ontological implications both in how to find race (i.e. how are we to know
when we have come upon race, and not something else), as well as in how to
acknowledge race as an object that is enacted. Just as race can materialise as an
object of concern, so too can it dissipate. To follow these moments necessitates
us not to settle into a critical binary of existence versus inexistence. I explore
these issues below to provide a conceptual foundation for the analytical work
that follows.
Finding Race
One of the most striking things I found in beginning the project I discuss in this
paper is how race felt like it was always there, and yet nobody really used the
term. The point of race’s multiplicity resonates with recent conceptual discussion
about scientific uses of race in the European context. Race in Europe has become
something of an absent presence. It is at once something that people are not com-
fortable discussing, but which is central to public policy and different forms of
personal, political and scientific practice. Race ‘oscillates between reality and
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nonreality, because it is not a singular object but rather a pattern of various
elements, some of which are made present and others absent’ (M’charek et al.,
2014, p. 462).
M’charek et al. go on to suggest that the absences and presences of race in these
different moments of oscillation are vital to recognising and to better understand-
ing the variegated work that race is put to.
The absent presence issue, though, throws up something of an analytic chal-
lenge that we can frame as something like: when do you know you are looking
at race, and not something else? This problematic sits at the heart of Peter
Wade’s discussion, in which he suggests that there tend to be two give-aways
that should alert us to the presence of race, even if the word itself is not being used:
What allows scholars to know when they are encountering something called
race is a combination of these two features: a reference to a specific set of
categories, located in a changing colonial history and geography, and an
idiom of nature (bearing in mind the variable character of that concept)
and more specifically ideas of heredity and transmission (bearing in mind
these are historically relative). (2014, p. 592)
We can know race, he thus argues, but allusions to categories—the racialised
apparatus of classification which, as Ian Hacking (2005) notes, sits at the heart
of colonial practices of control. The ‘idiom of nature’, too, is key here, recognisa-
ble in the mobilisation of heredity. When people suggest that difference is biologi-
cally transmitted through generations, Wade argues, we can know that race is near.
In this sense, like smoke implies fire, one can smell a racial logic in the mobilis-
ation of terms like ‘ancestry’, which requires us to locate ourselves both spatially
and temporally as individuals heralding from a certain place and point in time
(Kahn, 2015).
My initial confusion that words like ‘ethnicity’ were everywhere and race
nowhere made more sense, too, in light of the history of transplantation science,
which is shot through with geography and heredity, but far less so with direct dis-
cussions of race. Mid-twentieth-century immunologists, busy working on tissue
transplant treatments for leukaemia, were entertaining the idea that a human
might have a particular expression of antigens across all their cells that could
be either more or less compatible with another person’s body (Thomas et al.,
1957; Ferrebee et al., 1958; Thomas et al., 1959).
It was the advent of ‘a deeper understanding of the molecular meaning of indi-
viduality’ (Anderson and MacKay, 2014, p. 117) based on distinguishing the auto-
logous from the allogeneic, derived from the Greek autós (self) and állos (other).
This distinction is still central to transplantation science and, according to a recent
consensus paper, our HLA types are a combination of those of our parents (Erlich,
2012). Parentage and, through this, heredity are accordingly considered to be per-
tinent in the developing consensus around how tissue transplant practically works.
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In the 1970s, immunologists and population geneticists began working together,
becoming ‘obsessed with mapping patterns of HLA expression around the world’
(Anderson and MacKay, 2014, p. 129). In one well-known textbook from the field,
scientists explain that some HLA alleles are ‘absent . . . in East Asia and the Amer-
icas, Australia, New Guinea, and the Pacific islands and are therefore common
only in Eurafrica (Africa, and Europe . . .)’. Still others that are ‘relatively rare
in most of the world’ crop up in Australia and the surrounding islands, whilst
other alleles reach their ‘highest frequencies in America’ (Cavalli-Sforza et al.,
1994, p. 130).
Cavalli-Sforza et al., however, were reticent to speak of races exploring, at the
start of their book, the ‘scientific failure of the concept of human races’ (1994,
p. 19). Here, they noted that ‘The word “race” is coupled in many parts of the
world . . . with considerable prejudice.’ Fine-grained scientific analysis suggests
finer gradients to distinguish between ‘clusters’ and ‘populations’ of people, the
authors argue. A colour-coded map on the front cover depicts the spread of
genetic difference around these clearly defined spatialities of the globe. Race as
a term is disavowed whilst its signifiers (geography, heredity, classification) are
still there. As Fausto-Sterling notes of scholarship that speak of and visually
depicts human difference but does not say the word race—‘it stares out at us none-
theless’ (2004, p. 9). This is a point I have highlighted elsewhere in work mapping
out the institutional context of UK stem cell donation in which overtly racialised
language gets interchanged with descriptions of ‘genetic diversity’ as if they were
metonyms (Williams, 2015).
In stem cell transplantation science today, the word race is often avoided
altogether. Words of specific groups, like ‘Black’ or ‘Asian’, are common in
the UK context to denote specific populations. This resonates with Catherine
Bliss’ (2011) exploration of the conceptual slippage of racialised language in
her systematic literature review of the use of race in genomic research. That
these slippages exist reveals how these terms are not simply ‘out there’, but are
always fashioned by us (Morning, 2014).
To speak of the HLA frequencies of Europe, for example, one might easily slip
into speaking of Europeans which could have several synonyms. If you are ‘Euro-
pean’ in one instance, you could be ‘Caucasian’, ‘White’ or ‘Caucasoid’ in another
even though each permutation bears a different etymology and application, not
unsurprising given the intensely contextual nature of how we name and divide our-
selves (see Hinterberger, 2012a). As readers will note below, other terms like
‘population’, ‘minorities’ or ‘ethnicity’, are called upon by interviewees to articu-
late those groups that can be differentiated by the likelihood of having particular
HLA frequencies.
A term like ethnicity, argue sociologists of race Carter and Dyson, allow scho-
lars to discuss fixed qualities in people ‘without using disreputable notions of race’
(2011, p. 966), whilst others suggest the notion of ‘ethnic minority’ carries with it
its own baggage of racialising and racist consequences (see M’charek et al., 2014).
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More than this, though, there are particular continuities between these different
terms that give off the scent of race. In Peter Wade’s words, we can ‘detect
when a discourse or practice that is not explicitly racial acts in a racializing
way’ (2014, p. 588). For him, as for others (see Fujimura and Rajagopalan,
2011) combinations of human biology and geography (like that which we see in
stem cell transplantation) share clear resonances with more familiar racial
categories.
As such, I avoid participating in ‘the intricate and ever-recommencing defini-
tional casuistry’ that Rogers Brubaker locates in scholarly commentaries on
race and ethnicity (2004, p. 11). My suggestion here is that one need not use
the word race (indeed, as we have seen above, some might actively not use it)
to refer to the notion of biological heredity that we might recognise as racial.
Indeed, it is perhaps even more important to seek out and interrogate race when
it, to use Wade’s language, ‘hides in racialized concepts’ like ethnicity or popu-
lation (2014, p. 594) given, the political tendency towards coding race into less
problematic terminology that implies—without actually saying—race (Solomos,
1989).
Enacting Race
Having laid out what I mean by race as something that cannot necessarily be cap-
tured by the word, but which often is embedded in other racialised concepts like
ethnicity, I want to flesh out the analytic attention I give to race as something
enacted in various ways to different ends. It is useful here to mention Annemarie
Mol’s ethnographic work on atherosclerosis, a disease that she argues takes on
different permutations in different treatments, specialities and places. Her over-
arching point is that objects such as disease ‘come into being—and disappear—
with the practices in which they are manipulated’ (Mol, 2002, p. 5). Her influential
contribution to what she describes as medicine’s ontological politics, is instructive
in how Amade M’charek develops her conceptual understanding of race.
In M’charek’s formulation, race is, just like disease, a contingent object that
emerges through various practices. Its meanings and enactments are not stable,
but multiple. For her, race is neither existent nor inexistent and, indeed, she
eschews the common binary in which race is either a fact or a fiction, suggesting
it simultaneously is both fact and fiction, in the sense that it does not have a singu-
lar location beyond the networks and practices that produce it. Rather than being
‘out there’, race is a ‘relational entity enacted “in here”’ (M’charek, 2013, p. 421).
Different enactments produce different objects that do not necessarily look like
one another.
Attending to the various enactments of race, as I seek to do in the following
section of the paper, is a key way of showing how race, given its slippery multi-
plicity, cannot be forced into the positivistic box of provable biological fact, or
explained away through social constructionism. We are better, as I seek to do
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ahead, to plot out the practices through which race comes into focus and is—to use
Mol’s parlance—enacted. Indeed, as M’charek notes, it is through the contrast of
‘different practices, that we come across different versions of an object—versions
that do not easily add up to produce a whole and that may coexist in tensions or
even clash with one another’ (2010, p. 309). Indeed, we can find interactions of
the racial in which the word race is altogether absent.
The above conversation about finding race is entangled in the conceptual notion
of enactment. Drawing on John Law, M’charek et al. note the increasingly ‘absent
presence’ of race. State and institutional actors often seek to infer race (be they
specific racial groups, or the notion itself) without actually using the word. When-
ever race is mobilised in this more implicit way, it becomes impractical—perhaps
impossible—‘to simply follow the explicit use of the race concept’. This high-
lights the need for analytic light-footedness in the sense of being attentive to
moments in which biological heredity and human classifications which give off
the scent of race, are folded into apparently less loaded terminology like ethnicity,
population or otherwise.
M’charek analyses three cases—a near-diagnosis of Down’s syndrome, a
murder case where suspects were identified through CCTV, and a thirteenth-
century skeleton discovered and DNA typed who became the ‘face’ of a Dutch
city. The cases highlight in a powerful way how race, so often black boxed as
simply a locatable, biological ‘thing’ or an erroneous concoction of the social,
is ‘made relevant and materializes in a variety of ways, from medical sensibility
to legal arrangements and tactics in criminal investigation, to national identity and
historic tie making’ (M’charek, 2013, p. 424). Taking my lead from this perspec-
tive, I consider how within one scientific context—blood stem cell transplan-
tation—race again has a multiplicity of materialisations across a number of
different moments, from recruitment of donors, to inventory management and
tissue selection.
Its moments of enactment and silence—just some of which I want to trace here—
are important in recognising that mobilisations of race in this context cannot be
binarised as either fact/fiction, natural/social, existent/inexistent or—indeed—
right/wrong. As Schwartz-Marı́n and Wade remind us, in noting the more and
less malleable moments of race’s invocation, we do well to be attentive towards
the ‘domains in which people are imagining and plotting relations of being and
belonging’ (2015, p. 887). Race’s enactment in various contexts absolutely deter-
mines the shape it takes as an object and, indeed, the extent of its visibility.
Enacting Race in the Blood Stem Cell Inventory
The UK’s publically available AD registries and UCB banks are some of the most
established in the world. The first AD registry was developed in the UK in the
1970s, whilst the UK was one of the first European countries to establish its
own publically funded UCB bank. The network of banks and registries are
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managed by a public body, the National Health Service Blood and Transplant
Authority (NHSBT), and a charity called Anthony Nolan (see Anthony Nolan
and National Health Service Blood and Transplant, 2014; Anthony Nolan,
2015). In 2014, governance of these different sources was combined into a
single group, the Stem Cell Strategic Forum, which recommended shared
funding and a more collaborative search mechanism across these geographically
dispersed and managerially distinct entities. The period saw specific funding
awarded by the UK Department of Health to this network of registries and
banks, now called the UK’s ‘stem cell inventory’.
Empirically, the discussion I offer in this paper is informed by research under-
taken between 2012 and 2015 which was granted relevant ethical approvals by the
University of York, UK. The research included analysis of key public-domain
outputs produced by national and international charities and non-profit organis-
ations, the UK’s Department of Health and the UK’s parliamentary All-Party Par-
liamentary Group on Stem Cell Transplantation (herein, APPG). The APPG was
also used to locate interviewees for qualitative interviews with those involved in
the production of policy relating to the UK’s UCB collection arrangement (n ¼
19). These individuals spanned a number of different professional spheres, and
included stem cell banking personnel, recruitment and collection personnel, clini-
cal professionals, health activists and policy-makers. The span of interviewees
across these different spheres reveals, as I parse through the following analysis,
a number of distinctions and fissures between what race is useful for and how it
is enrolled in various practices of the UK’s blood stem cell inventory.
Basically Some Other Race—Race and Donor Recruitment
In this first section, I explore how race materialises in the practice of donating stem
cells. Specifically, individuals who want to donate are asked various questions,
usually through a form that they have to complete. These questions include
their gender, address, medical history and, via one term or another, some sense
of their racial identity. A nice example of this is the ‘ethnic group’ classification
scheme used by one AD registry and UCB bank (Anthony Nolan, 2013), which
instructs the volunteer donor to ‘give the best description of your ancestors’
origin’ by ticking a box in a list of some 43 options under seven headings.
These headings are ‘United Kingdom & Ireland (White)’, ‘Europe (White)’,
‘Other (White)’, ‘Africa and Caribbean (Black)’, ‘Asia (Asian)’, ‘Other’ and
‘Mixed Ethnicity’. In bold, donors are asked to ‘Please tick only one’ option.
One could not, for example, select both ‘Turkey’ (in the ‘Europe (White)’
section) and ‘Jewish’ (the ‘Other’ section). One could, however, select the
‘Mixed White & Other’ option from the ‘Mixed Ethnicity’ menu. Importantly,
they also note that ancestry ‘is not necessarily your nationality’. This fascinating
exercise where people are literally boxed into classifications based on their ances-
try reveals a moment in which race is enacted with a certain amount of fixity.
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A quote from a discussion with one of the individuals involved in designing the
scheme is reproduced below. Here they provide a description of the meeting where
it had been a topic of discussion. It reveals a significant amount of tension within
the field about how much value lay in this ostensibly administrative tool. A par-
ticular tension apparent here is between different groups involved in recruitment,
namely between the research scientists trying to guide recruitment practices, and
the recruiters doing the practical work of converting people in adult donor regis-
trants such as this interviewee, whose role is to encourage stem cell donation
through national awareness campaigns and smaller donation drives across the
country:
It was [the recruitment team] versus the researchers. We’ve got these major
categories, and then we’ve got minor categories underneath them. So we’ve
got mixed within each. British Irish, Asian, Northern European, and then
mixed within that . . . then we have also more major categories! And that
was the bit where I was like ‘Look, we’re doing recruitment events here!’
. . . In one of these meetings, we were talking about ‘what do you think is
far enough back to get a true identity?’ and one of our medical people was
like, ‘it’s grandparents’. I can’t run recruitment events where I say to
people ‘where were your grandparents born?’ It’s just not feasible. That’s
not the way that it works.(Adult donor registry administrator)
That racial classificatory schemes must be produced and agreed upon reveals in a
very profound way Ann Morning’s point, in her exploration of the use of race in
genetics, ‘that our categories are always ones that we fashion’ (2014, p. 1680). In
this account, one’s ‘true’ racial positioning according to the scientist is somewhere
in each person’s ancestral annals. A donor’s meaningful racial category can be
pinned down with a box tick. And yet the above interviewee struggles with the
impracticalities they see embedded in this scenario. They first describe with
some exasperation the length of the form, explaining all of the different options
and sub options within them. They also describe asking for guidance on ‘how
far back’ into family histories they must venture.
One might see this as an attempt to understand how best to operationalise a neb-
ulous term like ancestry which must be anchored down to a specific point for the
purpose of data collection. This is an issue taken up by Jonathon Kahn who notes
that ‘ancestry estimates implicate not only descent but also assumptions about
time and space’—which is to say, mobilising ancestry requires one to decide
when as well as where they are from (2015, p. 69). The answer, that they are
best to ask people to think of their grandparents’ birth place, is seen as ‘just not
feasible’, doubtless in part because recruitment events require the speedy conver-
sion of many would-be donors into registered volunteers who would not necess-
arily know where their grandparents were born, or might not want to part with
such information.
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Tidy lists of ‘ethnic groups’ reveal race as a stable and durable object. This
version of race ‘points in a different direction’ (M’charek, 2013, p. 423) from
how the recruiter envisions the events where this form is deployed. This iteration
is not feasible, its length and specificity renders it impractical to the work of
recruitment. From the scientist side rather than that of recruitment, a similar
amount of dissatisfaction with the manner in which the data are collected is appar-
ent. Herein, they describe how different feelings and affiliations essentially get in
the way of accessing the donor’s true race:
. . . it’s very hard to actually be sure that people know what ethnicities—in
genetic ways—they actually belong to. You sometimes have the case that
you have a great grandfather that was Chinese and due to that fact the
whole family regards itself as being Chinese which is not necessarily true
when all the other guys are basically some other race because after two gen-
erations, the racial indicator is gone . . . then when people answer and say
‘ok, I belong to that ethnicity’ due to some cultural feeling which is not
really reflected in their genes you get answers for the genetic way that do
not necessarily really reflect the true ethnicity. (Data analyst at adult
donor registry)
Tellingly, with reference to the vernacular slippage between different terms, this
interviewee uses both the explicit language of race (‘racial indicators’) and ethni-
city. Following Wade (2015), both terms here invoke the same racial logic of bio-
logical difference embedded in ideas of generational transmission. According to
this data analyst, a person might struggle to ‘know’ their ethnicity ‘in genetic
ways’. A great grandfather’s ethnicity is ‘not necessarily true’ for the generations
that follow him because the ‘indicator is gone’.
There are threads of biological reductionism that might be picked up from this
statement—particularly the idea that ‘some cultural feeling’ cannot be ‘reflected
in their genes’ which equates to their ‘true ethnicity’. This speaks to an assumption
that the social meaning of race is simply a misunderstanding of the actuality (i.e.
the scientific meaning) of race. This is the view that ‘racial categories are what you
get when social forces deform our apprehension of biological ancestry’ (Morning,
2014).
The jarring of the personal experience of race with this scientist’s view of what
‘true’ race is speaks to the complex intermingling of the different meanings
attached to racial identity, and that scientists’ attempts to regulate ‘true’ race
push against powerful familial and personal notions of identity. This is not to
say that there are two versions of race—the scientific and the cultural—that can
be, in different contexts, at odds and then in consensus. It is rather to suggest
that the invocation of race need not be stable in either its meaning or its use.
Race—which appears deceptively stable when put into a list that permits only
one selection—is not reducible to one thing. It is not always simply locatable in
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one’s ancestry—this might be pinned down to grandparents’ place of birth, but
even then, a person’s nationality, or a ‘cultural feeling’ might lead to an erroneous
conclusion of race. Rather, race appears in this context as always ‘a configuration,
an effect of relations between differences’ (M’charek, 2013, p. 435). The complex
work of recruitment enacts race here as a stable, fixed entity that can be incorrectly
communicated. And yet this conceptualisation of race sits uncomfortably next to
the practical work of recruiters who do not necessarily have the luxury of tracing
family histories, seeking out and challenging people’s racial affiliations.
Lots of Babies, Good Diversity—Race and Inventory Management
Stem cell donor recruitment reveals a rather complex materialisation of race. In
the context of inventory management, race materialises in a very different way.
Away from the context of individual donors who can confound data capture
forms with conflicting cultural feelings, race becomes a descriptor of groups,
a method through which to delineate different sections of the stem cell inven-
tory. The practice of trying to measure the inventory in terms of race is done
to give some sense of what the inventory contains now, and what it should
aim to contain. This simultaneously produces race as a set of highly stable
groups.
In 1999, 98% of UK stem cell registrants were classified as ‘European Cauca-
soid’ (Armitage et al., 1999). Looking towards the censuses on either side of this
statistic reveals why the figure is so important. The census, itself noted as a conduit
for the institutionalisation of racialised classification (see Hacking, 2005), is per-
formed every decade in the UK and all households are obliged to complete it. The
actual parameters of the UK population who are ‘white’ were 93% in 1991 and
87% in 2001. The 1999 figure of 98% white volunteer donors constitutes a
clear skew.
As Brown et al. note, this is in part because AD registries enjoy ‘strong histori-
cal penetration amongst advantaged middle class blood donors but recruit less
well beyond the mainstream demographic’ (2011, p. 1117). Many who are not
from this mainstream (we might read, white) demographic are accordingly under-
represented in the AD registry.
Since then, the composition of the registry has changed. Now, only around 76%
of donors fall into the European Caucasoid category (Anthony Nolan, 2015). Why
the change? Blood stem cell science has been caught up in a broader social discus-
sion around health equity—that is, if recipients are more likely to match donors
with similar ancestries, it is seen as incumbent upon this national health resource
to provide a spread of ancestries to serve the various patients who might need
them. This is evident in efforts to make the inventory more ‘representative’ in a
bid to ameliorate health inequalities. Classifications like white, Black and
Asian, have become a means through which one can measure whether or not
the inventory ‘mirrors’ the public it serves.
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This prioritisation is due to the contribution of large charities, like Anthony
Nolan, and small charities working in tandem with them such as the African Car-
ibbean Leukaemia Trust. Together, they have been trying to focus collection of
AD volunteer details and saliva and blood samples in Black and Asian commu-
nities (see Merz and Williams, under review). But despite this, as of 2015,
these groups remain ‘underrepresented’. This historic and continuing demo-
graphic deficit of individuals who do not self-identify as white on the AD registries
in part explains the UK’s motivation to collect UCB.
Those professionally interested in UCB in the 1990s viewed it as having the
capacity to penetrate particular demographics unaddressed by existing AD regis-
tries (Wagner et al., 1996). Indeed, UK policy explicitly highlights the role of
UCB in addressing health inequality:
Patients from ethnic minorities are particularly disadvantaged. This is
because HLA types are related to ethnicity and ethnic minority donors are
underrepresented on registries . . . This impacts substantially on the pro-
spects of ethnic minorities successfully locating a match . . . The banking
of umbilical cord blood offers an opportunity to reduce this inequality. It
is difficult to increase the representation of specific ethnic minorities on a
volunteer donor panel, but considerably more practicable to focus collection
of cord blood at hospital maternity units that serve populations with rela-
tively high levels of ethnic diversity. (UK Stem Cell Strategic Forum,
2010, pp. 17–19)
It is instructive to pause and think specifically about how race is being enacted
here as though it were a stable entity; ethnic minorities’ HLA types are
‘related’ to their ethnicity. Finding healthy ethnic minorities and placing their
tissue into the inventory is an ‘opportunity’ to reduce inequality. During an
APPG presentation on the composition of the UK’s UCB banks and AD registries,
the speaker described ‘an element of underrepresentation on the larger registers
[which] don’t necessarily . . . match the census data [on] the percentage of an
ethnic minority in the UK population’ (APPG notes, September 2013).
The construction of a pie chart-like composition of the banks—so many white
donors, so many Asians and so on—speaks to a particularly stable enactment of
race wherein all Asian donors go in one sector, all Black donors in another.
Here, we are not talking about fine-grained molecular analyses of HLA types,
but simply of getting enough Asian and Black people in order to address the
dearth of Asian and Black people. This becomes a game of probabilities
playing out along distinct, racialised lines of difference. Maximising donations
from particular groups heightens the chance of matches. This is not a question
of specific donors, but of specific, raced groups of donors.
Emerging out of these accounts, too, is the importance of the specificity of the
UK’s population. It should, for example, be noted that public funding sits behind
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much of the public stem cell provision in the UK context, as well as the various
practices I am exploring here—the funding awarded to Anthony Nolan and
NHSBT was, for example, awarded by the UK state (NHS Blood and Transplant,
2011). In these accounts, we also see how the conceptualisation of a very ethni-
cally diverse nation state produces a particular expectation of what the publically
available stem cell collection should look like. This is an explicitly responsive
effort, through purposefully inclusionary practices, ‘to concerns about the stigma-
tization and discrimination of groups’ (Hinterberger 2012b, p. 218).
Indeed, the inclusionary practice here is one of focusing UCB donation collec-
tion in specific places, a point I have explored in more depth elsewhere (see Wil-
liams, 2015). With the aim of redressing underrepresentation, it of course makes
sense to question the spending of one’s resources on banking what are believed to
be common, ‘white’ stem cells when there is a lack of rare, ‘minority’ stem cells
that could be addressed through focused collection. A UCB collection coordinator,
for example, described how ‘A petition went on in Manchester by the MP . . . to
have a collection site opened there and that’s why [a collection site] ended up
in Manchester. Again, another place with lots of babies and good diversity’
whilst an APPG contributor explained the decision to collect at a London site
because it ‘has a huge number of ethnic minorities . . . You basically target the
region because that’s where there are lots of mothers of ethnic minority groups’.
The cities of Manchester and London are thereby framed as favourable collec-
tion sites because of the ‘huge number’ of ethnic minorities that live in them, a
point that is explicitly highlighted in a central 2010 policy document:
Since 45% of ethnic minority individuals live in and around London . . . it
follows that an ethnically diverse cord blood inventory may best be achieved
by collecting cord blood units primarily from London hospitals with mater-
nity units with over 5000 births per annum. (UK Stem Cell Strategic Forum,
2010, p. 35)
As is explained in this extract from the Stem Cell Strategic Forum report, commis-
sioned by a parliamentary minister in 2012, nearly half of the ‘ethnic minority
individuals’ of England live in London and its surrounding areas. To evidence
this claim, it uses census data from the 2001 census (UK Stem Cell Strategic
Forum, 2010). Through this, the collection managers attempt to focus more inten-
sely on geographic areas with higher numbers of non-white people. By focusing in
this way, their work actively excludes particular locations and the people in them.
Being the rare, non-white body becomes an attractive property for inclusion in the
bank.
A useful question to ask at this juncture is how race takes on such stability in its
materialisation here. It is not contested, and becomes enrolled as a useful way of
making strategic decisions. This, I suggest, is thanks partly to the scale of its enact-
ment—here it is not individual donors being discussed, but an entire population
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which is being regularly measured and classified (through censuses), and which is
therefore rendered knowable and open to geographic focus. With a very straight-
forward focus on incorporating a broader racial mix, a clear path is trodden of
selecting hospitals for collection based on census data.
When strategising with entire populations, race has a very different shape. It is
no longer an impracticality (the lengthy form during a recruitment drive), nor is it
something that people might misapply to themselves, classifying themselves
incorrectly. In a different context of practice—the practice of strategic manage-
ment—race has a very different tenor which is far more certain. In the move
away from individuals to population statistics, race is not something being
argued over between recruiters and scientists, but something that can be
counted on as a useful and practical way of managing an entire inventory of
human tissue.
It Is Already There in the HLA—Race and Tissue Selection
The point of tissue selection offers a different window from which to see race’s
multiplicity and the work that it is doing. This time, race is not a box to be
ticked, a misguided feeling, a grandparent’s birthplace, or a demographic refer-
ence point in the road to health equity. When a donor is being selected from the
inventory for a patient in need of a tissue transplantation, race as accounted for
by interviewees appears to recede in importance. For example, the quote below
is from an interviewee responding to a question about whether clinicians would
ever use donors’ race data when making a selection for their patient:
No, because the ethnicity tends to be the thing that determines the HLA type
. . . the importance of ethnicity is only in the HLA type. So your HLA types
are inherited, obviously, so certain populations have certain HLA combi-
nations. So that’s why it’s so important. Um, but yeah, as soon as you—
I’m not aware of any data, but as soon as you’ve the HLA match, it’s
quite likely that they’re from the same ethnic group anyway. (Stem Cell Stra-
tegic Forum contributor and clinical practitioner)
In this account, the reason given for clinicians not using donors’ ethnicity data is
‘because the ethnicity tends to be the thing that determines the HLA type’. The
interviewee conveys a surety that a match within an ‘ethnic group’ is ‘likely’ to
be the case (whilst noting that there are no data confirming this). I asked a prac-
titioner involved with the APPG the same question—would a clinician use such
ethnicity data in making a tissue selection. They reflected on their own experience
in response:
So we would take it into account, but there are other things that matter
before. So we’d match for HLA type . . . We match for viruses they may
have seen. We match for blood group. There’s all sorts of things we come
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down. So ethnicity could be in there if we had the information. I have never
had information, I don’t think, on the ethnicity.
RW: Ok, but if ethnicity is something that matters—
Well it’s already there.
RW: in the HLA?
Yeah, exactly.
This practitioner similarly notes that they ‘have never had information’ about
donor race. If they did, they ‘would take it into account’ but this would be
lower on the list of criteria considered in the process. Importantly, this account
suggests that race (a datum that the practitioner never has) is not as important
as HLA typology.
How the clinician chooses to describe this is telling. Ethnicity is ‘already there’
in the donor’s HLA type. In the preceding quote ethnicity ‘determines’ HLA. In
the one just above, race is enveloped by HLA. HLA is crucial, and race takes
on what I have described elsewhere as an almost metonymic position as HLA’s
less specific stand-in (Williams, 2015). This reveals something of the ontological
politics of the multiple views of the body at work here, as race oscillates ‘between
presence and absence’ (M’charek, 2013, p. 436), in this absent moment embedded
silently in the HLA of the individual donor. At another point, ethnic group is ‘so
important’ whilst simultaneously ‘the importance of ethnicity is only in the HLA
type’.
This brings into relief the contingency of the idea of race in this space. Its use-
fulness in the strategic domain of inventory management is plain, but its relevance
in the clinic is less clear-cut. Race thus occupies, in the contemporary scientific
domain, a complex position in which its usefulness is contextual, negotiated
and far from guaranteed. This account demonstrates the complex variability of
race, and reveals a moment where the relationality of race is laid bare. As
M’charek notes, race never ‘materializes in the body but rather in relations estab-
lished between a variety of entities, including bodies’ (2013, p. 434). This argu-
ment bears out in the moment at which a clinician assumes (‘it’s likely’) that
donors and recipients share ethnicity if they match.
Race in this sense is wholly relational between donor and recipient—in their
‘match’. As an example, the interviewee below is a scientist who analyses the
prevalence of different HLA types in registries across the world. I asked them
whether they would find it useful to have donors’ racial data in stem cell collec-
tions around the world:
You might think ‘okay [donors’ race] data could be better for scientific
evaluation,’ . . . but I think this is a very luxurious demand in the context
that we’re working in . . . It would be nice to have them all always HLA
typed at the best level . . . which we try to do but of course it’s timely and
a costly process.
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RW: That’s a priority over having everyone’s ethnicity data?
Yeah, of course. I mean the ethnicity data is nice to have and if you could get
it then it’s alright. But it’s not anything that I could imagine we would phone
up someone and ask people for that.
This account and the one above it, with their allusions to ‘other things that matter
before’, and the luxuriousness of demanding information on donor ethnicity,
reveal that in the context of tissue matching race sits somewhere in the periphery.
Clinical decision making focuses in on the level and quality of the match between
donor and recipient, along with a variety of other cellular and disease-specific
factors that figure into the protocols of tissue selection.
In this context, race seems almost irrelevant, a point that resonates with
M’charek’s assertion that there is, in the contemporary moment, a broader
phenomenon in which race does not just shuttle between presence and absence,
but between occupying a central position to being rendered essentially irrelevant.
We see this playing out in the stem cell context. Race becomes a key point of
reference for constructing and maintaining the inventory, and tracing how repre-
sentative of the UK population it can ever purport to be. Then it is important only
insofar as it inheres in the HLA of a human body. It slips away into insignificance
in the scientific work of tissue selection, when it is as if race’s job is done.
Conclusion
‘In practices’, Mol writes, ‘objects are enacted’ (2002, p. 31). Race is one such
object, and M’charek’s invitation to recognise and trace race’s multiplicity as
an object that materialises through its enactments in practice is one that this
paper has taken up. Here, I have sought to parse some of these various enactments
in a few of the practices of the blood stem cell inventory. Throughout practices of
donor recruitment, of inventory management, and of the selection of tissue for
transplantation, race is made relevant in a number of different ways.
In setting out to answer the question of how race is variously enacted in the
context of stem cell transplantation, I have aimed to ‘denaturalize without dema-
terializing’ race (M’charek, 2013, p. 424). Whilst race is not an essential quality
that inheres within an individual, it is mobilised through various practice in such a
way that it has clear materiality—a data form, a decision to collect tissue in one
place or not another, for example. In part, this effort is an attempt to address
the dearth of critical focus on race in the context of blood stem cell science.
The role of race has not been particularly prominent in a landscape of sociological
scholarship that has attended to other questions of capitalisation, promise and
futurity, and the gendered landscape of regenerative medicine (Waldby, 2006;
Dickenson, 2007; Martin et al., 2008; Waldby and Cooper, 2010).
Race begins to emerge in studies focusing more specifically on the public and
internationally networked initiatives to bank public stem cells in the manner
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considered in this paper. Most prominently, concern tends to sit with how immuno-
logical difference becomes a corporeal resource through which immunities can
essentially be stockpiled and exchanged (Brown et al., 2011; Brown and Williams,
2015). However, as this paper has sought to address, a sustained exploration of how
race figures in this context has not been made a central element of discussion. In par-
ticular, by focusing on three different areas within this context, I have sought to
bring into relief the multiple quality of the object of race.
In one case, it materialises as a datum that must be carefully captured early on in
the recruitment phase. We see this emerge in devices like ethnicity data collection
forms that invite stem cell donors to situate themselves within pre-given lists of
ethnicity ‘options’. Yet even by anchoring a fuzzy notion like ‘ancestry’ into
the specific question of the grandparent’s birthplace, race can confound and be
confounded. It can easily get in the way of the practical work of recruiting volun-
teer stem cell donors (a list can be too long, a question can be too problematic to be
feasible).
Race, too, can easily be mis-captured by a volunteer donor seen as too invested
in their cultural identity of having a great grandfather from China to acknowledge
their true ethnicity. But the language of ‘truth’ in this context should not lead us to
assume that there is some reality of race that might be reached through the thicket
of false enactments that conceal it. Instead, it is a case of recognising that race only
appears here through the practices that mobilise it.
Away from the practical issue of recruitment, in the domain of managing the
inventory, conceptualising it as a whole and comparing it to the national popu-
lation, race becomes strangely stable and easy. The work of producing a useful
inventory relies on clearly demarcated, racially identified donors. There are x
number of Asians in the UK population, but only y number in the UK’s stem
cell inventory. Boosting this number through the selective placement of UCB col-
lection centres addresses this issue.
Race is a locus around which the strategic placement of collection centres is
managed—more ethnic minority bodies around a maternity ward makes that
ward more attractive as a UCB collection site. Race is, in the same vein, a
means of determining how representative this stem cell collection is. The historic
underrepresentation of minority ethnicity donors in the stem cell inventory has
produced an active attempt to recruit more minority adult donors and encourage
more minority UCB donation.
Race’s enactment during tissue selection reveals yet another materialisation of
the object. In this practice, clinicians must lean on a great deal of information to
make their clinical decisions. Race might not figure at all in this moment as clin-
icians do not see donors’ data (for instance, whichever box they ticked in the
recruitment period). At most, race will be seen ‘in’ the HLA, enveloped in the
very antigens that individuals inherit from their ancestors, revealing a stark differ-
ence in how different practices enact race differently; details of donors’ racial
identities oscillate between important question and luxurious data.
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Multiple as they are, what might be the political consequences of race’s enact-
ments in blood stem cell science, a paradigm which is now inexorably connected
with treatment provision for a growing number of treatment protocols? To be able
to say that race is enacted through practices is a powerful conceptual tool against
the reification of race as an inherent and essential human quality—the cases
explored here demonstrate this in showing how difficult and contingent the
pinning down of a donor’s race is, for instance. But the enactment of race for
the purposes of producing a useful public health resource representative of
those who may require it also reorients us towards asking other questions.
For instance, if ‘traces of races’ (Schwartz-Marı́n and Wade, 2015, p. 888) can
be sniffed out in the decades-long history of blood stem cell science, why is it only
towards the end of the twentieth century that practices of strategic management
have been enacting race towards developing a maximally representative collec-
tion? Such a question, though it cannot be answered here, is a fundamentally pol-
itical one produced by analysing race as a multiple object. Not only can we ask
what enactments of an object materialise. We might also ask why enactments
take the shape they do, and why the particular practices that mobilise them
come to be.
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